Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine

Completed · Phase 2 · Has a placebo group

Conditions studied: Migraine

In brief

This study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treatment of migraine.

Key facts

Study ID

NCT06603623

Run by

Biohaven Therapeutics Ltd.

People needed

647

Starts

2024-10-10

Expected to finish

2025-03-28

Last updated by the study team

2026-02-25

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

• WR-PRI, LLC (Encino) — Encino, California, United States
• Cenexel CNS Los Alamitos — Los Alamitos, California, United States
• Clinical Research Institute — Los Angeles, California, United States
• WR-PRI, LLC (Newport Beach) — Newport Beach, California, United States
• Cenexel CIT IE — Riverside, California, United States
• Hasbani Neurology — New Haven, Connecticut, United States
• Ki Health Partners DBA/ New England Institute for Clinical Research — Stamford, Connecticut, United States
• Green Leaf Clinical Trials — Jacksonville, Florida, United States
• WR-MSRA (Multi-Specialty Research Associates) — Lake City, Florida, United States
• AppleMed Research Group — Miami, Florida, United States
• Ideal Research — Pembroke Pines, Florida, United States
• ForCare Clinical Research — Tampa, Florida, United States
• Premier Research Instiute — West Palm Beach, Florida, United States
• NeuroTrials Research, Inc. — Atlanta, Georgia, United States
• Velocity Clinical Research, Savannah — Savannah, Georgia, United States
• Chicago Headache Center & Research Center — Chicago, Illinois, United States
• Healthcare Research Network II, LLC — Flossmoor, Illinois, United States
• Velocity Clinical Research, Sioux City — Sioux City, Iowa, United States
• Integrated Clinical Trials Services — West Des Moines, Iowa, United States
• Collective Medical Research — Overland Park, Kansas, United States
• L-MARC Research Center — Louisville, Kentucky, United States
• Crescent City Headache & Neurology — Chalmette, Louisiana, United States
• DelRicht Research — New Orleans, Louisiana, United States
• Velocity Clinical Research, Rockville — Rockville, Maryland, United States
• MD First Research — Gilbert, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.